Welcome to the Sanofi Media Room

Our Media Room is designed to provide reporters with company and product news, as well as key facts, figures and background information.  To help you keep up with the latest news, we offer email alerts and RSS feeds.  If you are a reporter and have questions about the company or our products, visit the Media Contacts page.

Press Releases
May 4, 2023
DUPIXENT® (dupilumab injection) is now approved in Canada for the treatment of adult and adolescent patients (12+) with Eosinophilic Esophagitis

* This is the eighth indication for DUPIXENT® in Canada and its first in gastroenterology. MISSISSAUGA, ON, May 4, 2023 /CNW/ - sanofi-aventis Canada Inc. (Sanofi Canada) is pleased to announce...

May 1, 2023
Libtayo® (cemiplimab) in Combination with Chemotherapy now approved in Canada for the First-line Treatment of Advanced Non-small Cell Lung Cancer

* Approval marks second first-line indication in NSCLC and fifth indication for Libtayo® in Canada TORONTO, May 1, 2023 /CNW/ - sanofi-aventis Canada Inc. (Sanofi Canada) is pleased to announce...

May 1, 2023
Sanofi Canada and Diabetes Care Community announce a collaboration to support the emotional well-being journey of Canadians living with diabetes

sanofi-aventis Canada Inc. (Sanofi Canada) and Diabetes Care Community Inc. (DCC) are pleased to announce a collaboration to support the journey towards emotional well-being of Canadians living...

More »

Stay Updated
* Required Fields